PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $451 | -52.3% | 14,707 | -37.7% | 0.00% | -50.0% |
| Q2 2023 | $946 | -1.5% | 23,615 | +0.4% | 0.01% | 0.0% |
| Q1 2023 | $960 | -55.3% | 23,517 | -57.7% | 0.01% | -74.2% |
| Q4 2022 | $2,147 | -99.8% | 55,614 | +225.8% | 0.03% | +158.3% |
| Q2 2022 | $995,000 | +35.9% | 17,069 | +40.2% | 0.01% | -20.0% |
| Q3 2020 | $732,000 | -34.2% | 12,173 | -50.4% | 0.02% | -28.6% |
| Q4 2019 | $1,113,000 | +24.5% | 24,567 | +4.7% | 0.02% | -32.3% |
| Q3 2019 | $894,000 | -57.1% | 23,473 | -51.1% | 0.03% | -62.7% |
| Q2 2019 | $2,086,000 | +522.7% | 47,958 | +516.0% | 0.08% | +245.8% |
| Q4 2018 | $335,000 | – | 7,786 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |